One of the most common questions I hear in my orthopedic clinic surrounds the use of peptides. The evidence for peptide injections improving muscle mass and function is limited and varies significantly by peptide type. Collagen peptides show the most robust evidence when combined with resistance training, while growth hormone-releasing peptides demonstrate modest effects. BPC-157 lacks human clinical data despite promising preclinical results.
Collagen Peptides (Oral, Not Injectable)
Collagen peptides taken orally combined with resistance training significantly improve body composition and muscle strength. A meta-analysis of 19 studies found statistically significant effects favoring collagen peptide supplementation for fat-free mass. A 15-week trial demonstrated greater increases in quadriceps volume and total muscle volume with collagen peptides versus placebo. However, collagen peptides showed no effect on myofibrillar protein synthesis in older males when not combined with exercise, unlike whey or pea protein which increased integrated muscle protein synthesis rates.
Growth Hormone-Releasing Peptides (Injectable)
Growth hormone secretagogues like capromorelin demonstrate modest improvements in lean body mass and physical function in older adults. In a randomized trial of 395 adults aged 65-84, capromorelin increased lean body mass at 6 months, with improvements in tandem walk and stair climb. However, adverse effects included fatigue, insomnia, and small increases in fasting glucose and insulin resistance. GHRH injections in elderly men improved some measures of muscle strength (upright row, shoulder press) but did not consistently improve physical function or IGF-I levels.
BPC-157 (Injectable)
BPC-157 shows promise in preclinical models for muscle healing and recovery but lacks human clinical evidence. Animal studies demonstrate accelerated healing of muscle injuries, including reversal of corticosteroid-impaired muscle healing. A 2026 review in the American Journal of Sports Medicine emphasizes that despite popularity, "significant research regarding the safety and efficacy of these therapeutic methods is required before definitive recommendations can be made to patients." Only a single human case series exists for BPC-157 (for knee pain), with significant methodological flaws and no controls.
Clinical Considerations
The evidence hierarchy clearly favors oral collagen peptides combined with resistance training over injectable peptides for muscle enhancement. Injectable growth hormone secretagogues show modest benefits but carry metabolic side effects. BPC-157 and similar "performance peptides" marketed for muscle recovery lack human validation despite extensive preclinical data.
Amit Momaya, MD is a board certified orthopedic surgeon who specializes in sports medicine. He serves as the Chief of Sports Medicine at UAB, resides on the editorial board of research journals, and takes care of several collegiate and professional teams in Alabama. This blog post is for educational purposes only. Please consult with your physician for a discussion on peptide use.
